World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
65
Citations
27687
World Ranking
8943
National Ranking
3970

Michael C. Milone publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Michael C. Milone sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 224 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Michael C. Milone D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Michael C. Milone sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 65 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Michael C. Milone is affiliated with the University of Pennsylvania in the United States. Their research primarily focuses on areas within medicine, with a substantial body of work in oncology, immunology, genetics, molecular biology, and biomedical engineering.

Their main research topics include:

  • CAR-T cell therapy research
  • Virus-based gene therapy research
  • Nanowire synthesis and applications
  • Immune cell function and interaction
  • Viral infectious diseases and gene expression in insects
  • T-cell and B-cell immunology
  • CRISPR and genetic engineering

Michael C. Milone has published extensively in several scientific venues. The most frequent venues of publication include:

  • Blood
  • Molecular Therapy
  • Regular and Young Investigator Award Abstracts
  • The Journal of Immunology
  • Nature Cancer

Their recent papers highlight significant contributions to immunotherapy and cellular engineering. Selected publications include:

  • "Rapid manufacturing of non-activated potent CAR T cells," 2022, Nature Biomedical Engineering
  • "Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers," 2020, JAMA Internal Medicine
  • "4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signaling," 2020, Science Signaling
  • "Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells," 2023, Nature Biotechnology
  • "Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris," 2020, Journal of Clinical Investigation

Frequent collaborators in their research include Selene Nuñez-Cruz, Carl H. June, Roddy S. O'Connor, Alfred L. Garfall, and Vijay Bhoj, evidencing established research partnerships in the field.

Best Publications

  • Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

    Stephan A. Grupp;Michael Kalos;David Barrett;Richard Aplenc

  • CAR T cell immunotherapy for human cancer

    Carl H. June;Roddy S. O’Connor;Omkar U. Kawalekar;Saba Ghassemi

  • Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

    David L. Porter;Wei-Ting Hwang;Noelle V. Frey;Simon F. Lacey

  • Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo

    Michael C. Milone;Jonathan D. Fish;Jonathan D. Fish;Carmine Carpenito;Richard G. Carroll

  • Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells

    Omkar U. Kawalekar;Roddy S. O’Connor;Joseph A. Fraietta;Lili Guo

  • Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains

    Carmine Carpenito;Michael C. Milone;Raffit Hassan;Jacqueline C. Simonet

  • Use of chimeric antigen receptor-modified t cells to treat cancer

    Carl H. June;Bruce L. Levine;David L. Porter;Michael D. Kalos

  • B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma

    Adam D. Cohen;Alfred L. Garfall;Edward A. Stadtmauer;J. Joseph Melenhorst

  • Clinical use of lentiviral vectors.

    Michael C. Milone;Una O’Doherty

  • Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease.

    Christoph T. Ellebrecht;Vijay G. Bhoj;Arben Nace;Eun Jung Choi

  • An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer

    Steven Feins;Weimin Kong;Erik F. Williams;Michael C. Milone

  • Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis

    Yan Xiang;Zachary E. Stine;Jinsong Xia;Yunqi Lu

  • Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors

    Edmund K. Moon;Liang-Chuan Wang;Douglas V. Dolfi;Caleph B. Wilson

  • Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells

    Matthew J. Frigault;Jihyun Lee;Maria Ciocca Basil;Carmine Carpenito

  • USE OF CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS TO TREAT MALIGNANCIES

    June Carl H;Porter David L;Kalos Michael D;Milone Michael C

  • Engineering Artificial Antigen-presenting Cells to Express a Diverse Array of Co-stimulatory Molecules

    Megan M Suhoski;Tatiana N Golovina;Nicole A Aqui;Victoria C Tai

  • Substrate Rigidity Regulates Human T Cell Activation and Proliferation

    Roddy S. O’Connor;Xueli Hao;Keyue Shen;Keenan Bashour

  • High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model.

    Sarah A. Richman;Selene Nunez-Cruz;Babak Moghimi;Lucy Z. Li

  • Beta-lactamases with improved properties for therapy

    Loew Andreas;Milone Michael C;Powell Daniel J;Zhao Yangbing

  • Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells

    Saba Ghassemi;Selene Nunez-Cruz;Roddy S. O'Connor;Joseph A. Fraietta

Frequent Co-Authors

Carl H. June
Carl H. June University of Pennsylvania
Bruce L. Levine
Bruce L. Levine University of Pennsylvania
David L. Porter
David L. Porter University of Pennsylvania
Simon F. Lacey
Simon F. Lacey University of Pennsylvania
Edward A. Stadtmauer
Edward A. Stadtmauer University of Pennsylvania
Michael Kalos
Michael Kalos Next Pillar Consulting
J. Joseph Melenhorst
J. Joseph Melenhorst University of Pennsylvania
Leslie M. Shaw
Leslie M. Shaw University of Pennsylvania
Stephan A. Grupp
Stephan A. Grupp Children's Hospital of Philadelphia
James L. Riley
James L. Riley University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens doors to many dynamic career pathways in health and life sciences. Many professionals find that supplementing their science background with applied, industry-relevant degrees can greatly expand career options and earning potential.

For those interested in the business side of science, earning a degree in healthcare management or an affordable online mba healthcare management can be a strategic next step. These programs can lead to roles in hospital administration, biotech management, or healthcare consulting.

If your interests lean towards mental health or direct patient care, consider the shortest pmhnp program to fast-track a career as a Psychiatric Mental Health Nurse Practitioner. Alternatively, those passionate about nutrition and wellness may opt for accelerated dietitian programs to become a registered dietitian faster.

Online, flexible, and accelerated degree pathways make it easier than ever to build on your science foundation, broaden your skills, and access rewarding careers in health, management, and specialized clinical roles.

Best Scientists Citing Michael C. Milone

Trending Scientists

Recently Published Articles